News Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Equities

P09

US69404D1081

Real-time BOERSE MUENCHEN Other stock markets 01:13:05 06/07/2024 am IST			5-day change	1st Jan Change
1.199 ^EUR	-3.56%		-2.98%	-86.74%

01/07	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 3000E Growth Index	CI
01/07	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2000 Growth Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 3000E Growth Index	01/07	CI
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2000 Growth Index	01/07	CI
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 3000 Growth Index	01/07	CI
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell Small Cap Comp Growth Index	01/07	CI
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2500 Growth Index	01/07	CI
PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry	27/06	MT
Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices	27/06	CI
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database	10/06	PR
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database	10/06	CI
Jefferies & Co Initiates Coverage on Pacific Biosciences of California With Buy Rating, $4 Price Target	03/06	MT
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	15/05	MT
Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $4 From $10, Maintains Equal-Weight Rating	15/05	MT
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	15/05	PR
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	15/05	CI
Piper Sandler Adjusts Price Target on Pacific Biosciences of California to $2 From $6.50, Maintains Neutral Rating	13/05	MT
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation	10/05	PU
Pacific Biosciences: Q1 Earnings Snapshot	10/05	AQ
Transcript : Pacific Biosciences of California, Inc., Q1 2024 Earnings Call, May 09, 2024	10/05
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M	10/05	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Equities

P09

US69404D1081

Summary

Filters